Office of Clinical Trials Management
The mission of the Office of Clinical Trials Management is to further the excellence, scope and efficiency of clinical research activities at the Rowan University-School of Osteopathic Medicine.
What is a Clinical Trial?
In a clinical trial (also called an interventional study), participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or changes to participants' behavior, for example, diet. Clinical trials may compare a new medical approach to a standard one that is already available or to a placebo that contains no active ingredients or to no intervention. Some clinical trials compare interventions that are already available to each other. When a new product or approach is being studied, it is not usually known whether it will be helpful, harmful, or no different than available alternatives (including no intervention). The investigators try to determine the safety and efficacy of the intervention by measuring certain outcomes in the participants. For example, investigators may give a drug or treatment to participants who have high blood pressure to see whether their blood pressure decreases. (Source: clinicaltrials.gov)
Currently Enrolling Trials:
If you are interested in the listed studies below and/or would like to obtain more information, please contact the Office of Clinical Trials Management (contact information on the right hand side).
EMR200136-573 : The purpose of this research trial is to compare how easy or difficult it is for patients to give themselves injections of Rebif® 44 mcg using the two different autoinjectors three times a week. The research trial is testing the devices in the treatment of a relapsing form of multiple sclerosis (MS). Both trial devices (autoinjectors) are approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple sclerosis and are being tested for patient preference. Each device administers Rebif®, a medication which is also approved by the FDA for the treatment of MS.
Obstetrics & Gynecology
M12-671: The purpose of this study is to evaluate an investigational drug called elagolix in subjects with moderate to severe pain associated with endometriosis (for example, painful menstruation, non-menstrual pelvic pain, and painful sexual intercourse). Subjects must be pre-menopausal and between the ages of 18-49, inclusive.
HC11515: The purpose of this study is to evaluate the efficacy of Transcranial Direct Current Stimulation (tDCS) in the treatment of major depression and bipolar depression. tDCS is noninvasive and has shown promising efficacy in recent studies. In this study, active tDCS will be compared with placebo treatment, but everyone will eventually have the opportunity to receive active treatment after the initial study period has ended. Participants will have their mood and cognition monitored regularly during the trial.
Current fibromyalgia pain treatments don't work for everyone. So we're conducting ALDAY - a medical research study to evaluate a potential new option. The study will last approximately 21 weeks and all study-related assessments and drugs will be provided at no cost to you (study-related time and travel costs may also be reimbursed). To learn how you could help shape the future of fibromyalgia care please call us at 856-566-6003.
If you would like to learn more about the Office of Clinical Trials Management, you may contact:
Mary Hammond, BSN
Phone: (856) 566-6003
Fax: (856) 566-2773